QIAGEN CLC Genomics
Circulating Tumor Cell Detection and Analysis to Support Malignancy Designation, Tumor-of-Origin Identification, and Treatment Selection
676 views
In this seminar, you’ll learn:
From Helena Silva Cascales, senior scientist at iCellate Medical AB, how the isolation of whole-tumor cells provides a more comprehensive biomarker analysis, including genomic sequencing and multiplexed protein expression analysis.
From Kashyap Dave, principal scientist at iCellate Medical AB, how DNA from single CTCs can be amplified, sequenced, and analyzed to support malignancy designation and tissue of origin identification using classification analyses under development within Qiagen CLC Genomics Workbench.
Related videos
QIAGEN CLC Genomics
QIAGEN CLC Genomics Workbench 20 – scalable desktop software for NGS data analysis
In this webinar, Leif Schauser, Ph.D., Director Product Management Genome...
QIAGEN CLC Genomics
De novo assembly, BLAST and genome finishing using QIAGEN CLC Genomics Workbench
This webinar will introduce users to the tools available for short reads...
QIAGEN CLC Genomics
Long-read sequencing analysis in the QIAGEN CLC Genomics Workbench
This tutorial is an introduction to working with the tools in the Long Read...
QIAGEN CLC Genomics
16S/18S/ITS sequencing analysis using CLC Genomics Workbench
QIAGEN CLC Microbial Genomics Module provides tools and workflows for a broad...